Tesamorelin 10MG
Find your strength. Choose your bundle.
233 in stock
Earn up to $6.00 back on this itemLazarus Pass · 1–5% store credit + free shipping protection · A$19.95/moA closer
look.
Tesamorelin is a synthetic, stabilised analogue of growth hormone–releasing hormone (GHRH) — the signalling peptide that acts on the pituitary GHRH receptor.
In research settings it is used as a reference compound for studying the GHRH receptor and the growth hormone / IGF-1 signalling axis.
Research details & references
Last reviewed:
Lazarus Labs supplies Tesamorelin in Australia as a 10 mg lyophilised reference material at ≥ 99 % purity, with a certificate of analysis for every lot. For research use only — not for human or veterinary use.
What is Tesamorelin?
Research context
Tesamorelin belongs to the GHRH-analogue family of research peptides, alongside growth-hormone secretagogues such as CJC-1295 and sermorelin. It is distinguished by structural modifications that improve its stability relative to native GHRH, which is why laboratories often select it as a consistent reference material in endocrine and metabolic-signalling studies.
Specifications
- Presentation: 10 mg per vial
- Purity: ≥ 99 %, confirmed by HPLC and LC-MS
- Form: white lyophilised powder
- Solubility: readily soluble in water (H₂O)
- Testing: every batch independently tested by Janoshik (HPLC + LC-MS)
- Documentation: third-party certificate of analysis per lot
- Intended use: in-vitro and laboratory research only
Quality & documentation
Every lot of Tesamorelin is independently tested by Janoshik Analytical. The certificate of analysis for your exact batch reports HPLC purity and LC-MS identity, so results stay traceable and reproducible across experiments. For deeper background, see our Tesamorelin research overview.
Handling & storage
Store sealed and dry at 2–8 °C. After reconstitution, store at controlled room temperature (20–25 °C), protected from light, and use within 7 days. Do not refrigerate or freeze; refrigeration may cause gelling in some reconstituted samples. Tesamorelin is supplied for research use only and is not for human or veterinary use.
Dispatch & supply in Australia
Tesamorelin ships from within Australia with tracked delivery, and every order includes the matching certificate of analysis.
Read the citation-backed research overview →
Cited research
- Stanley TL, et al Journal of Clinical Endocrinology & Metabolism. 2011. PMID: 20943777.
- Makimura H, et al Journal of Clinical Endocrinology & Metabolism. 2012. PMID: 23015655.
- Clemmons DR, Miller S, Mamputu JC PLoS One. 2017. PMID: 28617838.
- Badran AS, et al Obesity Research & Clinical Practice. 2026. PMID: 41545261.
Primary literature, verified against PubMed. Cited for scientific reference only — no human-use indication is implied.
The finer
details.
Check the product format, available strengths and intended use.
- Product
- Tesamorelin 10MG
- Intended use
- Laboratory research only
- Documentation
- See COA tab for strength and batch reports
Read the report.
Know the batch.
Compare the product, strength and batch on your vial with the original laboratory document.
Supplier batch report
- Batch
- LL-TESAMORELIN-0125
- Tested
- 2026-01-19
- Reported purity
- 99.704%
Reports identify tested batches. The available reports do not establish which batch will be dispatched with your order.
WA dispatch.
Tracked delivery.
Orders are dispatched from Western Australia with tracking. Check the selected product's availability and any pre-order notice before ordering.
Pre-order items follow their stated dispatch estimate. Orders containing pre-order items ship together once everything is available.
Shipping details →
